Cargando…
An orally available, small-molecule interferon inhibits viral replication
Most acute hepatitis C virus (HCV) infections become chronic and some progress to liver cirrhosis or hepatocellular carcinoma. Standard therapy involves an interferon (IFN)-α-based regimen, and efficacy of therapy has been significantly improved by the development of protease inhibitors. However, se...
Autores principales: | Konishi, Hideyuki, Okamoto, Koichi, Ohmori, Yusuke, Yoshino, Hitoshi, Ohmori, Hiroshi, Ashihara, Motooki, Hirata, Yuichi, Ohta, Atsunori, Sakamoto, Hiroshi, Hada, Natsuko, Katsume, Asao, Kohara, Michinori, Morikawa, Kazumi, Tsukuda, Takuo, Shimma, Nobuo, Foster, Graham R., Alazawi, William, Aoki, Yuko, Arisawa, Mikio, Sudoh, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277087/ https://www.ncbi.nlm.nih.gov/pubmed/22355771 http://dx.doi.org/10.1038/srep00259 |
Ejemplares similares
-
Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
por: Hada, Natsuko, et al.
Publicado: (2023) -
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
por: Matsumoto, Masahiko, et al.
Publicado: (2013) -
Self-Enhancement of Hepatitis C Virus Replication by Promotion of Specific Sphingolipid Biosynthesis
por: Hirata, Yuichi, et al.
Publicado: (2012) -
Establishment of infectious HCV virion-producing cells with newly designed full-genome replicon RNA
por: Arai, Masaaki, et al.
Publicado: (2011) -
In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
por: Watanabe, Tsunamasa, et al.
Publicado: (2014)